A decrease of 1-SD in serum albumin levels corresponded to HR of 1.16 (1.09–1.22), 1.16 (1.05–1.28), and 1.13 (1.03–1.23) for total, vascular and cancer mortality, respectively. This evidence concerns the gene ALB and cancer.